Mia M. Gaudet, PhD
Director, Genetic Epidemiology
Dr. Gaudet earned her B.A. in Dietetics from the University of Florida in 1997, followed by a master’s (1999) and doctoral (2005) degree in Epidemiology from the University of North Carolina at Chapel Hill. From 200 to 2007, Dr. Gaudet completed postdoctoral training at the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. Following previous faculty positions at Memorial Sloan-Kettering Cancer Center and Albert Einstein College of Medicine, Dr. Gaudet joined the research staff at the American Cancer Society.
Dr. Gaudet is a cancer epidemiologist with primary interests in genetic susceptibility, hormonal pathways, and the etiology and prognosis of breast and endometrial cancers. She has evaluated the role of genetic variation in relationship to cancer risk using candidate and genome-wide approaches in high risk and general populations. She is also conducting research in biological mechanisms mediating the association between breast and endometrial cancer and energy imbalance, including sex steroid hormones, insulin/insulin growth factor-axis, adipokines, and metabolomic profiles. By examining both serum markers and genetic variants in these pathways, she is utilizing a comprehensive approach to determine how energy imbalance relates to cancers of the breast and endometrium in several large prospective and case-control studies. Aberrations in these pathways may alter expression of important oncogenes and tumor suppressor genes leading to cancer initiation and progression.
Contact Email: firstname.lastname@example.org
Recent Representative Publications
Gaudet MM, Patel AV, Sun J, Hildebrand JS, McCullough ML, Chen AY, Gapstur SM. (2012) Prospective studies of body mass index with head and neck cancer incidence and mortality. Cancer Epidemiol Biomarkers Prev. 2012 Mar;21(3):497-503. Epub 2012 Jan 4.
Gaudet MM, Kirchhoff T, Green T, Vijai J, Korn JM, Guiducci C, Segrè AV, McGee K, et al. (2010) Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. PLoS Genet. 2010 Oct 28;6(10):e1001183.